1. Home
  2. STOK vs FUN Comparison

STOK vs FUN Comparison

Compare STOK & FUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

N/A

Current Price

$26.01

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Logo Cedar Fair L.P.

FUN

Cedar Fair L.P.

N/A

Current Price

$10.88

Market Cap

1.9B

ML Signal

N/A

Company Overview

Basic Information
Metric
STOK
FUN
Founded
2014
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2019
2023

Fundamental Metrics

Financial Performance
Metric
STOK
FUN
Price
$26.01
$10.88
Analyst Decision
Strong Buy
Buy
Analyst Count
14
14
Target Price
★ $46.46
$20.69
AVG Volume (30 Days)
638.1K
★ 1.8M
Earning Date
11-03-2026
11-06-2026
Dividend Yield
N/A
★ 11.20%
EPS Growth
★ 92.73
N/A
EPS
★ N/A
N/A
Revenue
$184,420,000.00
★ $3,100,289,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$39.98
$3.92
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 404.50
14.45
52 Week Low
$20.32
$10.86
52 Week High
$40.22
$27.37

Technical Indicators

Market Signals
Indicator
STOK
FUN
Relative Strength Index (RSI) 38.05 25.41
Support Level $25.21 N/A
Resistance Level $33.92 $17.97
Average True Range (ATR) 1.15 0.58
MACD -0.17 -0.08
Stochastic Oscillator 36.31 0.00

Price Performance

Historical Comparison
STOK
FUN

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About FUN Cedar Fair L.P.

Six Flags Entertainment Corp is North America's regional amusement resort operator with approximately 27 amusement parks, around 15 separately gated water parks, and nine resort properties across the U.S., Canada, and Mexico. It provides coasters, themed rides, thrilling water parks, resorts, and a portfolio of beloved intellectual properties such as Looney Tunes, DC Comics, and PEANUTS. The parks are family-oriented, with recreational facilities for people of all ages, and provide clean and attractive environments with exciting rides and immersive entertainment. The Company generates revenue from sales of admission to the amusement parks and water parks, from purchases of food, merchandise and games both inside and outside the parks, from the sale of accommodations and other extra-charge.

Share on Social Networks: